Specialty Pharmacy: Challenges & Opportunities

a DMD White Paper

In the past 5 years, growth in specialty pharmaceuticals has been exponential, with specialty drugs representing three out of every five drugs approved by the FDA in 2016 alone. This growing market opens the door to tremendous opportunities that simultaneously creates many hurdles.

This report, the 3rd in a DMD series, discusses challenges and opportunities faced by stakeholders in the specialty pharmaceutical space.

IN THIS WHITEPAPER:

   Hurdles in management of patient care
   Shifting focus to patient outcomes
   SPP specialization opportunities